J2690
J2690 – Injection, procainamide hcl, up to 1 gm · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 13 NDCs crosswalked per 1 GM $295.361/unit ASP+6%
📋 J2690 summary
J2690 is a HCPCS Level II J-code used to bill procainamide hcl, up to 1 gm, billed per 1 GM. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2690: Procainamide Hydrochloride, Procainamide Hci
Code J2690
Billing unit 1 GM Payment limit $295.361/unit NDC-Crosswalk 13
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2690
DescriptorInjection, procainamide hcl, up to 1 gm
Billing unit1 GM
Payment limit / unit$295.361
Est. ASP / unit$278.642 est.
Mapped NDCs13
Data periodQ3 2026
Last updated2026-08-20
💊 About Procainamide DRUG GUIDE
Procainamide hydrochloride injection is used to treat documented, life-threatening ventricular arrhythmias — most notably sustained ventricular tachycardia (a dangerously fast heart rhythm originating in the lower chambers of the heart).
Because of its serious risk profile, it is reserved for situations where the benefit clearly outweighs the risk.Procainamide is not recommended for minor or asymptomatic arrhythmias, and treatment should always be started in a hospital setting where close monitoring is possible.
Antiarrhythmic drugs, including procainamide, have not been shown to improve survival in patients with arrhythmias that are not life-threatening.
Clinical overview from our editorial drug guide for Procainamide. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$295.361
Est. ASP / unit
$278.642 est.
Est. after 2% sequester
$289.454
HCPCS dosage
1 GM
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, procainamide hcl, up to 1 gm
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment groupYY
Action codeP — Payment change
Effective date2024-01-01
Date added1982-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2690 = 1 gm. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2690 WITH EST. MEDICARE PAY
13 NDCs map to J2690. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($295.361/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00409-1902-01 | Procainamide Hydrochloride 100 mg/mL INJECTION, SOLUTION | Hospira, | 25 CARTON in 1 CASE (0409-1902-01) / 1 VI... | 100 mg/mL | 25 | $7,384.03 | — | ● Active | CMS + PDAC |
| 14789-0900-02 | Procainamide Hydrochloride 500 mg/mL INJECTION | Nexus | 10 VIAL, MULTI-DOSE in 1 CARTON (14789-900... | 500 mg/mL | 10 | $2,953.61 | — | ● Active | CMS ASP |
| 14789-0901-10 | Procainamide Hydrochloride 100 mg/mL INJECTION | Nexus | 10 VIAL, MULTI-DOSE in 1 CARTON (14789-901... | 100 mg/mL | 10 | $2,953.61 | — | ● Active | CMS ASP |
| 25021-0322-10 | Procainamide Hydrochloride 100 mg/mL INJECTION, SOLUTION | Sagent | 10 VIAL in 1 CARTON (25021-322-10) / 10 m... | 100 mg/mL | 10 | $2,953.61 | — | ● Active | CMS + PDAC |
| 25021-0323-02 | Procainamide Hydrochloride 500 mg/mL INJECTION, SOLUTION | Sagent | 10 VIAL in 1 CARTON (25021-323-02) / 2 mL... | 500 mg/mL | 10 | $2,953.61 | — | ● Active | CMS ASP |
| 51662-1334-01 | PROCAINAMIDE HCI 100 mg/mL INJECTION, SOLUTION | HF | 1 VIAL, MULTI-DOSE in 1 CARTON (51662-1334... | 100 mg/mL | 1 | $295.36 | — | ● Active | CMS ASP |
| 51662-1334-03 | PROCAINAMIDE HCI 100 mg/mL INJECTION, SOLUTION | HF | 25 POUCH in 1 BOX (51662-1334-3) / 1 VIAL... | 100 mg/mL | 25 | $7,384.03 | — | ● Active | CMS ASP |
| 51662-1630-03 | PROCAINAMIDE HYDROCHLORIDE 100 mg/mL INJECTION | HF | 5 POUCH in 1 CASE (51662-1630-3) / 1 BOX... | 100 mg/mL | 5 | $1,476.81 | — | ● Active | CMS ASP |
| 65145-0155-10 | Procainamide Hydrochloride 100 mg/mL INJECTION, SOLUTION | Caplin | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-155... | 100 mg/mL | 10 | $2,953.61 | — | ● Active | CMS ASP |
| 65145-0156-10 | Procainamide Hydrochloride 500 mg/mL INJECTION, SOLUTION | Caplin | 10 VIAL, MULTI-DOSE in 1 CARTON (65145-156... | 500 mg/mL | 10 | $2,953.61 | — | ● Active | CMS ASP |
| 76329-3399-05 | Procainamide Hydrochloride 100 mg/mL INJECTION | International | 5 SYRINGE in 1 PACKAGE (76329-3399-5) / 1... | 100 mg/mL | 0.1 | $29.54 | — | ● Active | PDAC |
| 51927-3115-00 | PROCAINAMIDE HCL (U.S.P.) | Unknown | — | — | 1 | $295.36 | — | — | PDAC |
| 00409-1903-01 | PROCAINAMIDE HCL 500 MG/ML | Unknown | — | — | 0.5 | $147.68 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$24.1K
Claims
79
Beneficiaries
52
Spend / beneficiary
$463.95
Spend / claim
$305.38
Trend by period
Where J2690 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #643 of 824
#638
ARANESP(J0882) J0882
$25.4K
#639
VINCASAR PFS* J9370
$24.6K
#640
HYPERHEP B* 90371
$24.3K
#641
ENOXAPARIN SODIUM* J1650
$24.3K
#642
METHOTREXATE SODIUM* J9260
$24.2K
#643
PROCAINAMIDE HCL J2690
$24.1K
#644
THIAMINE HCL J3411
$23.6K
#645
XERAVA J0122
$22.8K
#646
VINBLASTINE SULFATE J9360
$22.8K
#647
PROVOCHOLINE J7674
$22.4K
#648
MLG COMPLET, PER SQ... Q4256
$21.3K
Total claims — #650 of 824
#645
GEMCITABINE HCL(J919... J9196
86
#646
BKEMV Q5152
84
#647
METHOTREXATE* J8610
81
#648
PURAPLY 1 SQ CM** Q4195
80
#649
XWRAP 1 SQ CM** Q4204
80
#650
PROCAINAMIDE HCL J2690
79
#651
VALPROATE SODIUM J3379
79
#652
KEPPRA* J1953
75
#653
VASOPRESSIN-0.9% NAC... J2601
75
#654
CYGNUS DUAL PER SQ C... Q4282
75
#655
DOPAMINE HCL IN 5% D... J1265
74
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $24.1K | 52 | 79 | $463.95 | $305.38 |
| 2025 (Q1-Q4) | $63.9K | 198 | 257 | $322.65 | $248.58 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$1.4K
Medicare paid
$1.2K
Submitted services
54
Submitted charges
$1.4K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J2690 is utilized
⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.
📊 What bills under J2690
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
13 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2690 billing FAQ
What is HCPCS code J2690?
J2690 is a HCPCS Level II J-code used to bill Injection, procainamide hcl, up to 1 gm under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2690?
One unit of J2690 represents 1 GM. Report the number of units equal to the dose administered divided by 1 GM.
How many units of J2690 should I bill?
Divide the dose administered by the code's unit size (1 GM) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2690?
The Medicare Part B payment limit is $295.361 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $289.454 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2690?
13 NDCs currently map to J2690 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2690 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.